We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADN
4201
DELISTED
Advent Technologies
ADN
$11K ﹤0.01%
44
-7
-14% -$1.7K
AFBI
4202
DELISTED
Affinity Bancshares
AFBI
$11K ﹤0.01%
+835
New +$11.4K
AGX icon
4203
Argan
AGX
$7.84B
$11K ﹤0.01%
259
-423
-62% -$19.1K
AKA icon
4204
a.k.a. Brands
AKA
$116M
$11K ﹤0.01%
+106
New +$12.1K
AOUT icon
4205
American Outdoor Brands
AOUT
$161M
$11K ﹤0.01%
472
-1,499
-76% -$42K
AUBN icon
4206
Auburn National Bancorp
AUBN
$92.4M
$11K ﹤0.01%
308
+260
+542% +$8.93K
BSBR icon
4207
Santander
BSBR
$43.2B
$11K ﹤0.01%
+1,737
New +$12.5K
BSET icon
4208
Bassett Furniture
BSET
$170M
$11K ﹤0.01%
600
-5,588
-90% -$123K
CBNK icon
4209
Capital Bancorp
CBNK
$616M
$11K ﹤0.01%
447
-205
-31% -$4.59K
CCBG icon
4210
Capital City Bank Group
CCBG
$898M
$11K ﹤0.01%
457
-253
-36% -$6.03K
CDTX
4211
DELISTED
Cidara Therapeutics
CDTX
$11K ﹤0.01%
+244
New +$9.27K
CRBU icon
4212
Caribou Biosciences
CRBU
$160M
$11K ﹤0.01%
+470
New +$11.5K
CTKB icon
4213
Cytek Biosciences
CTKB
$636M
$11K ﹤0.01%
+509
New +$12K
CVRX icon
4214
CVRx
CVRX
$78.3M
$11K ﹤0.01%
+646
New +$12.4K
DMRC icon
4215
Digimarc Corp
DMRC
$158M
$11K ﹤0.01%
330
-2,504
-88% -$73.9K
ELTX icon
4216
Elicio Therapeutics
ELTX
$82.7M
$11K ﹤0.01%
113
+4
+4% +$432
EPHE icon
4217
iShares MSCI Philippines ETF
EPHE
$146M
$11K ﹤0.01%
360
+105
+41% +$3.1K
FHTX icon
4218
Foghorn Therapeutics
FHTX
$385M
$11K ﹤0.01%
821
-578
-41% -$6.4K
FLNT
4219
Fluent
FLNT
$132M
$11K ﹤0.01%
869
-1,586
-65% -$23.8K
FSBC icon
4220
Five Star Bancorp
FSBC
$1.16B
$11K ﹤0.01%
467
+52
+13% +$1.25K
FSBW icon
4221
FS Bancorp
FSBW
$326M
$11K ﹤0.01%
306
-790
-72% -$27.1K
GDDY icon
4222
GoDaddy
GDDY
$12.7B
$11K ﹤0.01%
164
-2,764
-94% -$214K
GDRX icon
4223
GoodRx Holdings
GDRX
$1.27B
$11K ﹤0.01%
+259
New +$9.4K
CBIO
4224
Crescent Biopharma
CBIO
$618M
$11K ﹤0.01%
51
-107
-68% -$22.7K
GRND icon
4225
Grindr
GRND
$2.74B
$11K ﹤0.01%
1,084
+600
+124% +$6.04K

Similar funds

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.